Peter Johansson

2.7k total citations
50 papers, 1.2k citations indexed

About

Peter Johansson is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Peter Johansson has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 20 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Peter Johansson's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers), Acute Myeloid Leukemia Research (9 papers) and Eosinophilic Disorders and Syndromes (9 papers). Peter Johansson is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers), Acute Myeloid Leukemia Research (9 papers) and Eosinophilic Disorders and Syndromes (9 papers). Peter Johansson collaborates with scholars based in Sweden, United States and Germany. Peter Johansson's co-authors include Björn Andréasson, Jack Kutti, Soodabeh Safai‐Kutti, Jan Samuelsson, Gunnar Birgegård, Ruben A. Mesa, Robyn M. Scherber, Börje Ridell, Alessandro M. Vannucchi and Francesco Passamonti and has published in prestigious journals such as Blood, Journal of Bone and Mineral Research and Clinical Chemistry.

In The Last Decade

Peter Johansson

49 papers receiving 1.1k citations

Peers

Peter Johansson
Michael R. Grunwald United States
Gabriela Hobbs United States
Ahmad Naim United States
Alexandra Bazeos United Kingdom
Melody J. Cunningham United States
Emily Riehm Meier United States
Avril A. Fitzgerald Canada
Áurea Lima Portugal
Toby Simon United States
Zahra Pakbaz United States
Michael R. Grunwald United States
Peter Johansson
Citations per year, relative to Peter Johansson Peter Johansson (= 1×) peers Michael R. Grunwald

Countries citing papers authored by Peter Johansson

Since Specialization
Citations

This map shows the geographic impact of Peter Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Johansson more than expected).

Fields of papers citing papers by Peter Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Johansson. The network helps show where Peter Johansson may publish in the future.

Co-authorship network of co-authors of Peter Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Johansson. A scholar is included among the top collaborators of Peter Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Johansson. Peter Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adamsson, Jenni, Peter Johansson, Staffan Nilsson, et al.. (2023). The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in Oncology. 13. 1190305–1190305. 1 indexed citations
2.
Cella, David, Peter Johansson, Yasutaka Ueda, et al.. (2023). Clinically important change for the FACIT-Fatigue scale in paroxysmal nocturnal hemoglobinuria: a derivation from international PNH registry patient data. Journal of Patient-Reported Outcomes. 7(1). 63–63. 16 indexed citations
3.
Mellström, Dan, Peter Johansson, Magnus K. Karlsson, et al.. (2022). Anemia is associated with increased risk of non-vertebral osteoporotic fractures in elderly men: the MrOS Sweden cohort. Archives of Osteoporosis. 17(1). 85–85. 10 indexed citations
4.
Cella, David, Peter Johansson, Yasutaka Ueda, et al.. (2021). Clinically Important Difference for the FACIT-Fatigue Scale in Paroxysmal Nocturnal Hemoglobinuria: A Derivation from International PNH Registry Patient Data. Blood. 138(Supplement 1). 1952–1952. 15 indexed citations
5.
Andréasson, Björn, et al.. (2020). ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patients. British Journal of Haematology. 189(5). 913–919. 12 indexed citations
6.
Johansson, Peter, et al.. (2020). Increased Risk of Hip Fracture in Patients with Lymphoma, a Swedish Population Study of 37,236 Lymphoma Patients. Calcified Tissue International. 106(6). 591–598. 3 indexed citations
7.
Michallet, Anne‐Sophie, Melih Aktan, Wolfgang Hiddemann, et al.. (2018). Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study. Haematologica. 103(4). 698–706. 50 indexed citations
8.
Aktan, Meryem, Anna Schuh, Peter Johansson, et al.. (2015). Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study. Leukemia & lymphoma. 56. 149–149. 10 indexed citations
9.
Andréasson, Björn, Jan Samuelsson, Malin Hultcrantz, et al.. (2013). Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms. Leukemia & lymphoma. 54(10). 2226–2230. 37 indexed citations
10.
Merup, Mats, Gunnar Birgegård, Lorentz Brinch, et al.. (2011). The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries. Bone Marrow Transplantation. 47(3). 380–386. 43 indexed citations
11.
Johansson, Peter, Ruben A. Mesa, Robyn M. Scherber, et al.. (2011). Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms. Leukemia & lymphoma. 53(3). 441–444. 41 indexed citations
12.
Johansson, Peter. (2011). Sociala rättigheter och migration. Det svenska pensionssystemet i internationella situationer 1946-1993. RePEc: Research Papers in Economics. 1 indexed citations
13.
Ridell, Börje, et al.. (2010). The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. European Journal Of Haematology. 86(2). 148–155. 55 indexed citations
14.
Girodon, François, Peter Johansson, Marc Maynadié, et al.. (2008). AML transformation in 56 patients with Ph− MPD in two well defined populations. European Journal Of Haematology. 82(2). 106–111. 55 indexed citations
15.
Albertsson, Maria, Jonas Bergh, Gunnar Birgegård, et al.. (2007). Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations. Medical Oncology. 24(3). 267–272. 4 indexed citations
16.
Johansson, Peter, Jack Kutti, Björn Andréasson, et al.. (2004). Trends in the incidence of chronic Philadelphia chromosome negative (Ph‐) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983–99. Journal of Internal Medicine. 256(2). 161–165. 48 indexed citations
17.
Johansson, Peter, Björn Andréasson, Soodabeh Safai‐Kutti, et al.. (2003). The presence of a significant association between elevated PRV‐1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. European Journal Of Haematology. 70(6). 358–362. 18 indexed citations
18.
Johansson, Peter, Anne Ricksten, Lovisa Wennström, et al.. (2003). Increased risk for vascular complications in PRV‐1 positive patients with essential thrombocythaemia. British Journal of Haematology. 123(3). 513–516. 18 indexed citations
19.
Johansson, Peter, Soodabeh Safai‐Kutti, Göran Lindstedt, Madis Suurküla, & Jack Kutti. (2002). Red Cell Mass, Spleen Size and Plasma Erythropoietin in Polycythaemia vera and Apparent Polycythaemia. Acta Haematologica. 108(1). 1–7. 8 indexed citations
20.
Johansson, Peter, et al.. (2002). On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Västra Götaland region, Sweden. Journal of Internal Medicine. 251(4). 348–354. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Grunwald Breakdown of academic impact, for papers by Gabriela Hobbs Breakdown of academic impact, for papers by Ahmad Naim Breakdown of academic impact, for papers by Alexandra Bazeos Breakdown of academic impact, for papers by Melody J. Cunningham Breakdown of academic impact, for papers by Emily Riehm Meier Breakdown of academic impact, for papers by Avril A. Fitzgerald Breakdown of academic impact, for papers by Áurea Lima Breakdown of academic impact, for papers by Toby Simon Breakdown of academic impact, for papers by Zahra Pakbaz
Rankless by CCL
2026